Document is current

Any future updates will be listed below

Correction to: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Crossref DOI link: https://doi.org/10.1186/s12935-021-02401-0

Published Online: 2021-12-20

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark